To anticipate potential resistance mechanisms, we carried out an in vitro functional screening to identify genes conferring MET inhibitor resistance to GTL-16, a MET-addicted gastric carcinoma cell line with high level amplification of the MET gene locus. The gene discussed is MET; the disease is gastric carcinoma.